Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1989 Jul;82:9–17. doi: 10.1289/ehp.89829

The effect of dose, dose rate, route of administration, and species on tissue and blood levels of benzene metabolites.

R F Henderson 1, P J Sabourin 1, W E Bechtold 1, W C Griffith 1, M A Medinsky 1, L S Birnbaum 1, G W Lucier 1
PMCID: PMC1568113  PMID: 2792053

Abstract

Studies were completed in F344/N rats and B6C3F1 mice to determine the effect of dose, dose rate, route of administration, and rodent species on formation of total and individual benzene metabolites. Oral doses of 50 mg/kg or higher saturated the capacity for benzene metabolism in both rats and mice, resulting in an increased proportion of the administered dose being exhaled as benzene. The saturating air concentration for benzene metabolism during 6-hr exposures was between 130 and 900 ppm. At the highest exposure concentration, rats exhaled approximately half of the internal dose retained at the end of the 6-hr exposure as benzene; mice exhaled only 15% as benzene. Mice were able to convert more of the inhaled benzene to metabolites than were rats. In addition, mice metabolized more of the benzene by pathways leading to the putative toxic metabolites, benzoquinone and muconaldehyde, than did rats. In both rats and mice, the effect of increasing dose, administered orally or by inhalation, was to increase the proportion of the total metabolites that were the products of detoxification pathways relative to the products of pathways leading to putative toxic metabolites. This indicates low-affinity, high-capacity pathways for detoxification and high-affinity, low-capacity pathways leading to putative toxic metabolites. If the results of rodent studies performed at high doses were used to assess the health risk at low-dose exposures to benzene, the toxicity of benzene would be underestimated.

Full text

PDF
9

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bechtold W. E., Sabourin P. J., Henderson R. F. A reverse isotope dilution method for determining benzene and metabolites in tissues. J Anal Toxicol. 1988 Jul-Aug;12(4):176–179. doi: 10.1093/jat/12.4.176. [DOI] [PubMed] [Google Scholar]
  2. Eastmond D. A., Smith M. T., Irons R. D. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol Appl Pharmacol. 1987 Oct;91(1):85–95. doi: 10.1016/0041-008x(87)90196-7. [DOI] [PubMed] [Google Scholar]
  3. Henderson R. F., Sabourin P. J., Bechtold W. E., Griffith W. C., Medinsky M. A., Birnbaum L. S., Lucier G. W. The effect of dose, dose rate, route of administration, and species on tissue and blood levels of benzene metabolites. Environ Health Perspect. 1989 Jul;82:9–17. doi: 10.1289/ehp.89829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Latriano L., Goldstein B. D., Witz G. Formation of muconaldehyde, an open-ring metabolite of benzene, in mouse liver microsomes: an additional pathway for toxic metabolites. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8356–8360. doi: 10.1073/pnas.83.21.8356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Maltoni C., Conti B., Cotti G., Belpoggi F. Experimental studies on benzene carcinogenicity at the Bologna Institute of Oncology: current results and ongoing research. Am J Ind Med. 1985;7(5-6):415–446. doi: 10.1002/ajim.4700070508. [DOI] [PubMed] [Google Scholar]
  6. Maltoni C., Conti B., Cotti G. Benzene: a multipotential carcinogen. Results of long-term bioassays performed at the Bologna Institute of Oncology. Am J Ind Med. 1983;4(5):589–630. doi: 10.1002/ajim.4700040503. [DOI] [PubMed] [Google Scholar]
  7. Raabe O. G., Bennick J. E., Light M. E., Hobbs C. H., Thomas R. L., Tillery M. I. An improved apparatus for acute inhalation exposure of rodents to radioactive aerosols. Toxicol Appl Pharmacol. 1973 Oct;26(2):264–273. doi: 10.1016/0041-008x(73)90261-5. [DOI] [PubMed] [Google Scholar]
  8. Sabourin P. J., Bechtold W. E., Birnbaum L. S., Lucier G., Henderson R. F. Differences in the metabolism and disposition of inhaled [3H]benzene by F344/N rats and B6C3F1 mice. Toxicol Appl Pharmacol. 1988 Jun 15;94(1):128–140. doi: 10.1016/0041-008x(88)90343-2. [DOI] [PubMed] [Google Scholar]
  9. Sabourin P. J., Bechtold W. E., Henderson R. F. A high pressure liquid chromatographic method for the separation and quantitation of water-soluble radiolabeled benzene metabolites. Anal Biochem. 1988 May 1;170(2):316–327. doi: 10.1016/0003-2697(88)90637-9. [DOI] [PubMed] [Google Scholar]
  10. Sabourin P. J., Chen B. T., Lucier G., Birnbaum L. S., Fisher E., Henderson R. F. Effect of dose on the absorption and excretion of [14C]benzene administered orally or by inhalation in rats and mice. Toxicol Appl Pharmacol. 1987 Feb;87(2):325–336. doi: 10.1016/0041-008x(87)90294-8. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of American Chemical Society

RESOURCES